American Association for Cancer Research
Journalists: See bottom of this post for video and audio resources
The dietary supplement gamma-linolenic acid can inhibit the growth of a subset of pancreatic cancer cells and selectively promote cancer cell death in mice, say Mayo Clinic researchers. The supplement, a fatty acid also known as GLA, worked particularly well when combined with the chemotherapy drug gemcitabine, the researchers say. The findings were presented today by Mayo Clinic pathologist Ruth Lupu, Ph.D., at the American Association for Cancer Research conference.
Journalists: The following video and audio clips with Dr. Lupu are available for download and use in your stories:
Below is an edited youtube video of Dr. Lupu discussing the study, It may be embedded into your stories.